Han Xiao is a postdoctoral fellow in Prof. Carolyn R. Bertozzi’s lab at Stanford University. He received his B.S. in chemistry and an honors degree in physical science from the University of Science and Technology of China (USTC). He conducted undergraduate research in Prof. Liu-Zhu Gong’s group, focusing on organic methodology and synthesis of natural products. Han Xiao did his graduate work at the Scripps Research Institute. His thesis work with Prof. Peter G. Schultz focused on expanding the technique of genetically incorporating unnatural amino acids in both prokaryotic and eukaryotic organisms and applying this technique for better cancer therapeutics. In 2015, Han jointed the laboratory of Prof. Carolyn R. Bertozzi at the Stanford University. In his postdoctoral work, he is engaged in the development of novel cancer immune therapy targeting the cell-surface glycans axis of immune modulation. Enzymatic precision glycocalyx editing is able to simultaneously stimulate immune activating pathways and limit immune inhibitory pathways within immune cells. Thus, precision glycocalyx editing with antibody-enzyme conjugates is therefore a promising avenue for cancer immune therapy. His awards include Aldrich Alfred R. Bader Award for Student Innovation (Sigma-Aldrich Co. LLC), Outstanding Self-Financed Students Abroad (Ministry of Education of the People’s Republic of China) and National Scholarship (Ministry of Education of the People’s Republic of China).